Conditions
Obstructive Sleep Apnoea
7 articles published between June 30, 2025 and October 3, 2026.
Covered in Body, Children & Family Health, Men's Health and Sleep.
WHAT THE STUDY ACTUALLY SAYSIn TRIUMPH-1, a triple hormone-receptor agonist produced a 25% average weight loss at the top dose over 80 weeks, and also eased knee pain and sleep apnoea. The trial was funded by Eli Lilly.
3 min read
EXPLAINEROccasional snoring is common in young children and often harmless. Loud, habitual snoring with pauses in breathing can mean obstructive sleep apnoea — a treatable problem that surgery can improve.
3 min read
EXPLAINERNocturia is usually blamed on the prostate, but the commonest driver is the kidneys making too much urine overnight. In one trial, low-dose desmopressin trimmed nightly voids and bought about 40 extra minutes of sleep.
3 min read
ANALYSISA Lancet review triangulates the evidence linking adiposity to multisystem disease and finds robust trial support in a short list — while an expert panel argues the drugs must be lifelong.
4 min read
ANALYSISA systematic review of longitudinal MRI after CPAP for sleep apnoea finds changes reported in every domain and reproducible effects in none — a useful map of what the evidence does not yet show.
3 min read
WHAT THE STUDY ACTUALLY SAYSA 4,066-person survey series across Funafuti and the outer islands links second-hand smoke exposure — reported by 61% of participants — to obesity and elevated STOP-Bang scores.
4 min read
WHAT THE STUDY ACTUALLY SAYSApplying prevalence figures to UN population data yields 852 million adults with insomnia. Only 31 of 237 countries had a usable national estimate of their own.
3 min read
This page indexes this newspaper’s reporting on Obstructive Sleep Apnoea. It is not a medical reference entry, and nothing here is medical advice. See our editorial standards.